They don't have to tell us everything. As others have pointed out here, there are competitive reasons for them to hold their data very tightly.
They have previously indicated that data from the Covid trial might be useful for the GVHD application.
https://hotcopper.com.au/posts/53299352/single
Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA, page-1017
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.11 |
Change
0.015(1.37%) |
Mkt cap ! $1.261B | |||
| Open | High | Low | Value | Volume |
| $1.09 | $1.11 | $1.07 | $4.403M | 4.045M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 47 | 87584 | $1.11 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.11 | 221134 | 9 |
View Market Depth
| Last trade - 15.39pm 11/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |